More Business Wire
View Older Stories View Newer Stories-
TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance
-
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
-
FIS Completes Strategic Acquisition of Global Payments’ Issuer Solutions Business and Sale of Worldpay Stake
-
AN2 Therapeutics Announces FDA Clearance to Proceed with 90-Patient Investigator-Initiated Trial (IIT) of Epetraborole in Patients with M. abscessus Lung Disease
-
Ionis well-positioned for continued momentum and substantial value creation in 2026 with two new independent launches and several pivotal data readouts
-
Utz Brands, Inc. Announces Preliminary Fourth Quarter and Fiscal Year 2025 Results
-
Shake Shack Provides Fiscal Fourth Quarter 2025 Business Update
-
REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
-
SAGA Diagnostics® Launches Ultrasensitive Pathlight™ MRD Test in Colorectal Cancer
-
Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026
-
Aeva to Participate in the 28th Annual Needham Growth Conference
-
Ono to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Northwestern Medicine Selects Tempus to Expand Genomic Testing
-
Vince Holding Corp. Provides Holiday Sales Results
-
SmartCella and Catalent Sign Nonexclusive License Agreement for GMP iPSCs
-
Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-in-Class Gene Therapy for Rett Syndrome
-
Subaru Selects Dynamic Map Platform’s HD Map Data for New Advanced EyeSight® Driver Assist Technology
-
Everseen Unveils Everact: The First Agentic AI Platform for Conversational Retail Intelligence
-
Mobileye Announces Timing of its Fourth Quarter and Full Year 2025 Results
-
Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
-
Healthpeak Properties Announces $925 Million of Transaction Activity
-
Reed Duchscher Appointed to Funko Board of Directors
-
Genesco Reports Comparable Sales
-
Study Shows NuScale Power Technology Can Support Profitable, Reliable Power for Chemical Plants
-
Spire Global Successfully Launches 9 Satellites on SpaceX’s Twilight Mission
-
OneSpaWorld Announces Preliminary Fourth Quarter and Fiscal Year 2025 Revenue and Adjusted EBITDA and Introduces Fiscal 2026 Revenue and Adjusted EBITDA Guidance
-
Booz Allen Announces Partnership with Andreessen Horowitz to Accelerate and Scale Advanced Technology for Governments
-
ShareBuilder 401k Empowers the Self-Employed With Free Solo 401(k) Setup to Start the New Year
-
US Foods Reaffirms Fiscal Year 2025 Guidance
-
J.Jill, Inc. Raises Fourth Quarter Guidance Ahead of the 28th Annual ICR Conference
-
CitiTrends Announces 2025 Holiday Sales Results
-
WEX Advances Multi-Year Board Refreshment Plan
-
lululemon athletica inc. Updates Revenue and Earnings Expectations for the Fourth Quarter Ahead of the ICR Conference
-
Zura Bio Reports Business Updates and Outlook for 2026
-
Babcock & Wilcox to Participate in the 28th Annual Needham Growth Conference on January 16, 2026
-
Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK’s B7-H3 Antibody Drug Conjugate (ADC)
-
USANA Health Sciences Provides Preliminary Fiscal Year 2025 Net Sales and Issues Initial Fiscal Year 2026 Net Sales Outlook
-
Circle K Helps Customers Recover from Holiday Spending with 40 Cents off Per Gallon on Jan. 15
-
KBRA Releases Research – 2026 European Project Finance and Infrastructure Sector Outlook: Stable Credit Quality Amid AI Energy Crosswinds
-
Banc of California Announces Schedule of Fourth Quarter 2025 Earnings Release and Conference Call
-
Seagate 32TB Capacities Now Shipping to Channel and Retail Partners Globally
-
Bio-Sourcing and Zerion Pharma Join Forces to Develop First HER2 Oral Monoclonal Antibody Against Breast Cancer
-
e.l.f. Cosmetics and Liquid Death Drop Limited-Edition “Lip Embalms”
-
QXO Upsizes Convertible Preferred Equity Placement to $3 Billion
-
Swiss Rockets Group and Alloy Therapeutics Partner to Advance Radioligand Therapeutics in Oncology
-
Savers Value Village, Inc. Announces Preliminary Fourth Quarter and Full Year Net Sales and Participation in the 28th Annual ICR Conference
-
H.C. Wainwright & Co., LLC Strengthens Healthcare Equities Franchise with the Addition of Jim Horvath
-
Summit Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA Seeking Approval for Ivonescimab in Combination with Chemotherapy in 2L+ Treatment of Patients with EGFRm NS
-
MedaSystems Reports Breakthrough Year of Global Growth, Clinical Trust, and Platform Expansion
-
PlusAI Launches Southern Europe’s First Autonomous Trucking Program with IVECO
